ElectroCore, Inc. Appoints Donald Melnikoff as SVP, Engineering, Regulatory, and Compliance
May 03, 2024 at 04:05 pm
Share
electroCore, Inc. announced that on May 1, 2024, Donald Melnikoff joined electroCore as the Company?s SVP, Engineering, Regulatory, and Compliance; the Compensation Committee of electroCore?s Board of Directors granted 10,000 restricted stock units (?RSUs?) to Mr. Melnikoff in connection with the commencement of his employment.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Companyâs product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Companyâs TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.